Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. This competitive grant highlights the scientific promise of MT-601, which targets multiple tumor antigens and has shown encouraging safety and efficacy in earlier studies. The funding will help Marker initiate a clinical trial in early 2027, aiming to improve outcomes in a cancer type with limited treatment options. Marker’s approach may offer a safer, more effective therapy by addressing tumor heterogeneity and antigen escape.
Marker Therapeutics' recent FDA grant news is presented here with relevant market context from Pluang. For readers following the health sector, 73 of 150 priced US health stocks rose while 47 fell as of Oct 19, 2026 18:01 WIB. Notable movers include BFLY at USD 7.38 with a 1-day change of +1.86%, ELAN at USD 23.97 up 1.78%, and LQDA at USD 33.76 down 1.72%.
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...
Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...
JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...
Haleon Canada is opening the Haleon Health House in Toronto on October 23, an immersive pop-up experience designed to educate visitors on everyday health through interactive exhibits and expert advice. The event features trusted Haleon brands like Ad...
